v3.26.1
Fair Value Measurements - Schedule of Instruments (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Other Investments:    
Beginning balance $ 687
Net unrealized gains [1] 68
Ending balance 755
Contingent Consideration:    
Beginning balance 11,844  
Remeasurement [2] 2,562
Ending balance $ 14,406
[1] Recorded in impairments and other losses, net in the Consolidated Statements of Operations.
[2] Recorded in remeasurement of contingent consideration in the Consolidated Statements of Operations.